MK-1308A is a combination of two medications, quavonlimab and pembrolizumab, that are used together to help the body’s immune system fight cancer. This combination is being tested to see if it can help people with a specific type of colorectal cancer that has certain genetic features, known as microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR). The goal is to see if this combination can shrink the cancer or stop it from growing.

Pembrolizumab is a medication that helps the immune system recognize and attack cancer cells. It is used on its own in this study to see how well it works in treating colorectal cancer with the same genetic features mentioned above. Researchers want to find out if pembrolizumab alone can effectively reduce the size of the cancer or halt its progression.

MK-4280A is another experimental treatment being tested in this study. It is designed to work with the immune system to target and destroy cancer cells. The study aims to determine if MK-4280A can be an effective treatment option for patients with the specific type of colorectal cancer being studied.

MK-7684A is a therapy that is also being evaluated in this clinical trial. Like the other treatments, it is intended to help the immune system fight cancer. The researchers are investigating whether MK-7684A can help control or reduce the cancer in patients with the genetic features of MSI-H or dMMR colorectal cancer.

MK-4830 combined with pembrolizumab is another treatment option being tested. MK-4830 is designed to enhance the immune system’s ability to attack cancer cells, and when used with pembrolizumab, it may offer a stronger response against the cancer. The study is looking to see if this combination can be more effective than other treatments in managing the cancer.

Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Cancer – This is a type of colorectal cancer characterized by genetic mutations that affect the DNA repair process, leading to high levels of microsatellite instability. In stage IV, the cancer has spread beyond the colon to other parts of the body, such as the liver or lungs. The disease progresses as cancer cells continue to grow and spread, forming new tumors in other organs. This type of cancer can cause symptoms like changes in bowel habits, blood in the stool, and abdominal pain. As the disease advances, it may lead to more severe symptoms due to the involvement of other organs. The progression of the disease is influenced by the genetic instability that allows cancer cells to multiply rapidly.